Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.
Riggs
B Lawrence
BL
Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
Hartmann
Lynn C
LC
D001842:Bone and Bones / Q000187:drug effects; D001940:Breast / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy / Q000517:prevention & control*; D002490:Central Nervous System / Q000187:drug effects; D003327:Coronary Disease / Q000517:prevention & control; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000187:drug effects; D020845:Selective Estrogen Receptor Modulators / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use; D014566:Urogenital System / Q000187:drug effects
D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride